Last update:

Gastroenterology news

C-reactive protein links to ventricular repolarization in coronary artery disease, study finds

A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally depending on whether a patient suffers from cirrhosis or acute/chronic coronary disease.

FDA-approved drug may reverse T-cell exclusion in fibrolamellar liver cancer

Immunotherapy—which activates the body's own immune system to kill cancer cells—has not worked well against a rare and fatal liver cancer, but a new study finds an existing FDA-approved drug may allow the immunotherapy ...

Studies show 11 genetic variants affect gut microbiome

In two new studies on 28,000 individuals, researchers are able to show that genetic variants in 11 regions of the human genome have a clear influence on which bacteria are in the gut and what they do there. Only two genetic ...

NSMF protein identified as key regulator in colorectal cancer

A research team affiliated with UNIST has unveiled a novel approach to halt the progression of colorectal cancer by inducing irreversible cellular aging. Their findings demonstrate that suppressing a neural protein called ...

Cholesterol crystals may trigger some liver disease

Cholesterol crystals in the liver may stiffen the organ early in those with metabolic dysfunction-associated steatotic liver disease (MASLD)—well before scarring develops—according to new research from a team in the Perelman ...

Pancreatic cancer: Warning signs to heed

Your pancreas has important jobs to do. A large gland behind the lower part of the stomach, it produces hormones that regulate blood sugar and enzymes that help digest food. What if it develops cancer?

Scientists create 'smart underwear' to measure human flatulence

Scientists at the University of Maryland have created Smart Underwear, the first wearable device designed to measure human flatulence. By tracking hydrogen in flatus, the device helps scientists revisit long-standing assumptions ...

Researchers develop a new model to study colorectal cancer

Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, resembling those seen in patients. ...

Common toxin linked to liver disease

Liver disease is usually caused by one of three factors: alcohol consumption, fat buildup in the liver linked to obesity, diabetes and high cholesterol, or hepatitis B and C.

Two-drug combination could improve colorectal cancer therapy

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown—only a few risk factors are known—and it is ...

Ingestible pill developed to diagnose intestinal disorder

Researchers led by investigators at Mass General Brigham and Massachusetts Institute of Technology have validated an ingestible capsule in preclinical models for the diagnosis of acute mesenteric ischemia, a condition caused ...

Zenocutuzumab shows clinical benefit in rare bile duct cancer

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...

Preventing malnutrition in people with blood cancer

Malnutrition is a common but difficult-to-manage complication for people with cancer, especially those treated with intensive chemotherapy. Now, new research from the University of Adelaide has delivered new insights into ...